Presentation Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI Presenter: J. Yu December 17, 2012 REGISTER for free or LOG IN to view this content Prevention CAD Pharma Clinical Pharma ACS/AMI Factoid Up Next Presentation Association of Clopidogrel Pretreatment with Mortality, CV Events, and Major Bleeding After PCI Presenter: A. Bellemain-Appaix December 17, 2012 More slides + Presentation The Prevalence and Outcomes of Transradial PCI for STEMI: NCDR CathPCI Registry, 2007-2011 Presenter: D.V. Baklanov December 18, 2012 Presentation Intraprocedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Pts Undergoing PCI for ACS Presenter: Sorin J. Brener December 19, 2012 We Recommend
Presentation Association of Clopidogrel Pretreatment with Mortality, CV Events, and Major Bleeding After PCI Presenter: A. Bellemain-Appaix December 17, 2012
Presentation The Prevalence and Outcomes of Transradial PCI for STEMI: NCDR CathPCI Registry, 2007-2011 Presenter: D.V. Baklanov December 18, 2012
Presentation Intraprocedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Pts Undergoing PCI for ACS Presenter: Sorin J. Brener December 19, 2012